BONESUPPORT’s incoming CEO acquires shares

Published: 2025-06-05

BONESUPPORT™, a leading company in orthobiologics for the treatment of bone disorders, today announces that incoming CEO Torbjörn Sköld has acquired 15,000 shares in BONESUPPORT at a price of 252,60 SEK per share. The total investment amounts to approximately 3,8 million SEK.

As previously communicated, Torbjörn Sköld will assume the role of CEO of BONESUPPORT on 1 September 2025.

For more information contact:

BONESUPPORT Holding AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 899 million in 2024. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

BONESUPPORT’s incoming CEO acquires shares